Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-26 @ 12:54 AM
NCT ID: NCT00921934
Description: None
Frequency Threshold: 1
Time Frame: 1.5 years
Study: NCT00921934
Study Brief: Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Vitamin C Adult patients suffering from acute viral infection, especially herpes zoster, presenting themselves in Primary Care Centers or hospitals all over Germany, and who are treated with standard therapy and add-on vitamin C. None None 0 68 2 68 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Sensation of heat on the injection site SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (14.0) View
numbness sensation up to the fingertips SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (14.0) View
burning SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (14.0) View
Urticarial drug inducted exanthema on truncus SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (14.0) View
Urticarial drug inducted exanthema on torso SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (14.0) View
protracted diarrhoe SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (14.0) View